Literature DB >> 33301217

Growth, Body Composition, and Lung Function in Prepubertal Children with Cystic Fibrosis Diagnosed by Newborn Screening.

Elizabeth Owen1, Jane E Williams2, Gwyneth Davies3, Colin Wallis4, Robert L Grant5, Mary S Fewtrell2.   

Abstract

BACKGROUND: Children with cystic fibrosis (CF) are at risk of altered body composition (BC). Newborn screening (NBS) may lead to improved BC outcomes. We investigated BC and its relationship with lung function in prepubertal children diagnosed with CF by NBS. Secondary aims explored predictors of fat-free mass (FFM) and lung function.
METHODS: Thirty-seven screened (non-meconium ileus) children with CF (20 boys) born 2007-2012 had a dual-energy x-ray absorptiometry scan at 5-8 years to determine whole-body (WB) and appendicular BC. Anthropometry was performed and routine spirometry recorded. Results were converted to z-scores, height-adjusted (fat mass index [FMI] and FFM index [FFMI]) and compared with population mean values. Predictors of forced expiratory volume in 1 second (FEV1 ) were assessed using linear regression.
RESULTS: Height, body mass index (BMI), and FEV1 were within normal limits, however, weight and BC were significantly low compared with reference data (weight, P = .03; WB FMI, P = .001; WB FFMI, P = .009). Gender differences were detected, with lower appendicular BC in boys and lower weight, BMI, and BC in girls. The association between FEV1 and WB FFMI (r = 0.38; P = .02) was stronger than with BMI (r = 0.29; P = .08). WB FFMI was the only significant predictor of FEV1 in a multivariable model (95% CI, 0.11-0.99; P = .016).
CONCLUSION: In this NBS CF population, gender differences in growth and BC were apparent despite preserved lung function. These results support BC assessment in prepubertal children, particularly girls, with an opportunity to direct interventions to optimize FFM.
© 2020 American Society for Parenteral and Enteral Nutrition.

Entities:  

Keywords:  body composition; cystic fibrosis; dual-energy x-ray absorptiometry; fat-free mass; newborn screening; pediatrics

Mesh:

Year:  2020        PMID: 33301217     DOI: 10.1002/ncp.10604

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  2 in total

Review 1.  Growth hormone therapy in short-stature patients with kyphoscoliosis: a literature review.

Authors:  Mariam S Alharbi
Journal:  EFORT Open Rev       Date:  2022-03-17

Review 2.  Trends in Growth and Maturation in Children with Cystic Fibrosis Throughout Nine Decades.

Authors:  Kelly A Mason; Alan D Rogol
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-12       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.